Anavasi Diagnostics
Anavasi Diagnostics is dedicated to providing rapid, accurate, and affordable molecular diagnostic testing solutions for infectious diseases, including COVID-19. Their mission is to support healthcare providers and workplaces with high-quality testing technology that ensures safety, efficiency, and reliability. They focus on innovation, quality control, and supporting community health through advanced diagnostic tools.
Industries
Nr. of Employees
small (1-50)
Anavasi Diagnostics
Products
Portable reusable molecular detector and associated RT-LAMP NAAT
A portable, reusable detector system paired with an RT-LAMP–based nucleic-acid assay for qualitative detection of SARS-CoV-2 RNA at the point of care; designed for rapid turnaround, per-sample internal control, and multiplex target redundancy.
Portable reusable molecular detector and associated RT-LAMP NAAT
A portable, reusable detector system paired with an RT-LAMP–based nucleic-acid assay for qualitative detection of SARS-CoV-2 RNA at the point of care; designed for rapid turnaround, per-sample internal control, and multiplex target redundancy.
Services
Provision of training materials, personalized onboarding sessions, certification assessments, and deployment support to integrate molecular diagnostics into clinical workflows.
Cloud service that captures, stores, and automatically reports test results to public-health reporting streams; supports QR-code transmission and scan-based patient data entry.
Provision of QC documentation, routine assay quality testing, and collaboration with third-party laboratories to maintain assay performance against emerging variants.
Provision of training materials, personalized onboarding sessions, certification assessments, and deployment support to integrate molecular diagnostics into clinical workflows.
Cloud service that captures, stores, and automatically reports test results to public-health reporting streams; supports QR-code transmission and scan-based patient data entry.
Provision of QC documentation, routine assay quality testing, and collaboration with third-party laboratories to maintain assay performance against emerging variants.
Expertise Areas
- Point-of-care molecular diagnostics
- NAAT assay design and RT-LAMP implementation
- Multiplex genomic assay design and variant resiliency
- Variant surveillance and in silico coverage analysis
Key Technologies
- Reverse-transcription loop-mediated isothermal amplification (RT-LAMP)
- Nucleic acid amplification testing (NAAT)
- Fluorescence-based optical detection
- Multiplex genomic target design
News & Updates
Anavasi Diagnostics offers the AscencioDx® system as a reliable alternative after Cue Health ceased operations, with comparable technology and benefits.
The company emphasizes the importance of rapid molecular testing for workplace safety and community health, supporting CDC and OSHA guidelines.
The company monitors SARS-CoV-2 variants such as Pirola (BA.2.86) and Eris (EG.5), ensuring their tests maintain high coverage and reliability.
Recent reports indicate a rise in COVID-19 cases driven by the Eris (EG.5) variant, which accounts for 17.3% of US cases and is spreading rapidly. Anavasi Diagnostics' tests continue to detect this variant effectively.
The article explains the importance of ongoing testing for new variants to ensure detection accuracy and public safety.
Guidance on workplace safety measures, including the use of rapid molecular tests like AscencioDx, to prevent COVID-19 spread.
Anavasi Diagnostics offers the AscencioDx® system as a reliable alternative after Cue Health ceased operations, with comparable technology and benefits.
The company emphasizes the importance of rapid molecular testing for workplace safety and community health, supporting CDC and OSHA guidelines.
The company monitors SARS-CoV-2 variants such as Pirola (BA.2.86) and Eris (EG.5), ensuring their tests maintain high coverage and reliability.
Recent reports indicate a rise in COVID-19 cases driven by the Eris (EG.5) variant, which accounts for 17.3% of US cases and is spreading rapidly. Anavasi Diagnostics' tests continue to detect this variant effectively.
The article explains the importance of ongoing testing for new variants to ensure detection accuracy and public safety.
Guidance on workplace safety measures, including the use of rapid molecular tests like AscencioDx, to prevent COVID-19 spread.